Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study.
Anjali Tiku OwensMegan B SuttonWei GaoJennifer T FineJipan XieSrihari S NaiduNihar R DesaiPublished in: Cardiology and therapy (2022)
Patients experienced high rates of treatment changes, and the economic burden associated with symptomatic obstructive HCM increased as therapy escalated. More effective therapies are needed to stabilize or decrease the economic burden of obstructive HCM.